Got $3,000? These Stocks Could Double Your Money by 2030

Underrated growth stocks like WELL Health Technologies (TSX:WELL) could double your investment by 2030.

| More on:

This bear market could be an ideal time to invest for long-term growth. The valuation of growth stocks has plummeted, as investors pivot to dividend-paying, mature companies. This opens up an opportunity for investors who’re willing to take a contrarian approach. 

If you have some cash, say $3,000, here are the top three stocks that could double that investment by 2030.

Aritzia

Luxury retailer Aritzia (TSX:ATZ) is outperforming the rest of the sector. The company continues to deliver revenue and earnings growth, as other retailers lay off staff and shut stores. In its latest quarter, the company reported a 37.8% surge in revenue and an 8.9% jump in net income. 

The management team has now laid out a plan for growth for the next five years. Aritzia expects to launch eight to 10 new stores every year for the foreseeable future. Many of these new stores will be located in the United States, where the company has seen faster growth and better profits. 

By 2027, the team hopes to raise revenue to $3.8 billion. That’s roughly 76% higher than its revenue expectation for fiscal 2023. If it meets this target, the company’s net profits should rise considerably higher. 

$3,000 invested in Aritzia could easily double by 2027, if not earlier. In fact, the company is so confident about its prospects that it has initiated a buyback scheme to repurchase up to 3,860,745 shares by next year. Keep an eye on this underrated growth opportunity.  

WELL Health

Another excellent growth stock is WELL Health Technologies (TSX:WELL). The company’s virtual healthcare and medical data management business has three similarities to Artizia. Firstly, it’s growing across the border in the United States. Secondly, it’s undervalued, as the stock has dropped 25% from its peak in 2022. Lastly, the company is actively buying back its shares. 

WELL Health is worth $900 million while it expects to generate over $550 million in recurring revenue this year. That’s a price-to-revenue ratio of 1.6 — one of the lowest in the tech sector. I expect WELL Health to continue to outperform and deliver growth in the years ahead. If the valuation adjusts as well, investors could easily double their investment in just a few years. There’s no reason why this shouldn’t be a multi-billion-dollar enterprise by 2030. 

goeasy

Subprime lender goeasy (TSX:GSY) is a little riskier than the other two stocks on this list. That’s because its business model is extremely sensitive to consumer credit and interest rates. In 2022, the Bank of Canada raised the benchmark rate of interest drastically. That’s why goeasy lost over 40% of its value. 

This year, concerns about inflation and rate hikes have abated. The Bank of Canada has paused rate hikes, and if the consumer proves to be stronger than expected, goeasy could surge. The stock trades at 13 times earnings and could double by 2030 if the credit cycle normalizes. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has positions in Well Health Technologies. The Motley Fool has positions in and recommends Aritzia. The Motley Fool has a disclosure policy.

More on Investing

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

How to Use Your TFSA to Double Your TFSA Contribution

If you're looking to double up that TFSA contribution, there is one dividend stock I would certainly look to in…

Read more »

Income and growth financial chart
Investing

A Top-Performing U.S. Stock That Canadian Investors Really Should Own

Amazon (NASDAQ:AMZN) is starting to run faster in the AI race, making it a top U.S. pick for 2025.

Read more »

Person uses a tablet in a blurred warehouse as background
Tech Stocks

2 Canadian AI Stocks Poised for Significant Gains

Here are two top AI stocks long-term investors may want to consider before the end of the year.

Read more »

man touches brain to show a good idea
Investing

3 No Brainer Tech Stocks to Buy With $500 Right Now

Here are three no-brainer tech stocks long-term investors on a limited budget may want to consider right now.

Read more »

woman looks at iPhone
Dividend Stocks

Retirees: Is TELUS Stock a Risky Buy?

TELUS stock has long been a strong dividend provider, but what should investors consider now after recent earnings?

Read more »

Concept of multiple streams of income
Dividend Stocks

Is goeasy Stock Still Worth Buying for Growth Potential?

goeasy offers a powerful combination of growth and dividend-based return potential, but it might be less promising for growth alone.

Read more »

A person looks at data on a screen
Dividend Stocks

How to Use Your TFSA to Earn $300 in Monthly Tax-Free Passive Income

If you want monthly passive income, look for a dividend stock that's going to have one solid long-term outlook like…

Read more »

Man holds Canadian dollars in differing amounts
Investing

Is Dollarama Stock a Buy?

Although Dollarama's stock is expensive and has rallied by more than 40% over the last year, is it still worth…

Read more »